Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in heart failure and diabetes mellitus
NCT02397421Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Mar 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in heart failure (HF), type 2 diabetes mellitus (T2DM), sponsored by University of Dundee. Started Mar 2015; status: completed.
02
Drugs
dapagliflozin
03
Conditions
heart failure (HF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02397421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02397421.